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Summary.-Lung primary carcinomas and normal tissue from 136 patients have
been extracted for prostaglandins, and the findings examined in relation to histology.
In most cases, tumours yielded more prostaglandin-like material (PG-lm), as
judged by bioassay, than did normal tissue from the same lungs. Amounts varied
with the tumour types, in the following ascending order: small-cell carcinomas,
large-cell undifferentiated carcinomas, well-differentiated squamous carcinomas,
poorly-differentiated adenocarcinomas, poorly differentiated squamous carcinomas,
and well-differentiated adenocarcinomas. Tumour PG-lm was highest when necrosis
or the neutrophil content of the tumours were moderate, whereas PG-lm from
normal lung tissue correlated with the number of macrophages. Chromatography
indicated the presence of various prostaglandins, in agreement with our recent
findings using gas chromatography-mass spectrometry.
PROSTAGLANDINS have been studied in
various human cancers (see Bennett, 1979,
1982). With breast carcinomas, the
amount of prostaglandin-like material
(PG-lm) extracted from the tumours or
formed by microsomal enzymes correlates
with tumour invasion and spread (Bennett
et al., 1977; Rolland et al., 1980), and
shows an inverse correlation with patient
survival Bennett et al., 1979). Prosta-
glandins in lung cancer have previously
been little studied (Sandler et al., 1968;
Hensby etal., 1982). Wenowreportinvesti-
gations of prostaglandins extracted from
different types of lung carcinoma, and
relate them to histological features. A
preliminary account of this work has
already appeared (Bennett et al., 1981).
PATIENTS AND METHODS
The studies were carried out on tissue from
171 patients undergoing pneumonectomy or
lobectomy for lung cancer at the Brook
Hospital, London. None of the patients had
received previous treatment for lung cancer.
The size of the fresh surgically-resected
lung tumour was measured, and part of the
tumour and macroscopically normal tissue
(usually taken from the edge of the specimen
at least 6 cm from the tumour) were provided
by a pathologist. Several representative
blocks of tumour retained by the pathologist
were examined by routine histology. The
samples given to us were put into con-
tainers and transported to the laboratory
on ice within 1 h of removal. They were
studied either immediately or, in 5 cases,
after overnight storage at 4°C. Before
extraction for prostaglandins, another sec-
tion of each tissue was prepared for a de-
tailed histological assessment. The remaining
tissues were cut finely with scissors, washed
several times withKrebssolutionandweighed.
One portion of each sample was homogenized
in Krebs solution:ethanol (1: lv/v) acidified
to approximately pH 3 with formic acid,
to yield basal amounts of tissue PG-lm.
The remaining portion was homogenized
in Krebs solution alone which allows new
prostaglandin synthesis from endogenous pre-
cursors released during homogenization (Ben-
nett et al., 1973). This PG-lm is referred to as
"total" since it reflects amounts of newly
synthesized+basal PG-lm. The individual
samples were extracted for prostaglandins
(Unger et al., 1971) and bioassayed on the ratPROSTAGLANDINS AND LUNG CANCER
fundus strip preparation in Krebs solution
containing various antagonists which im-
prove the selectivity and sensitivity of the
preparation (Gilmore et al., 1968; Bennett
et al., 1973). The activity in the sample was
assayed against PGE2 and the results ex-
pressed as ng PGE2 equivalents/g wet
tissue. Characterization of the extracted
PG-lm was carried out using various systems.
Extracts were chromatographed, with auth-
entic PGE1, E2, E3, Fl,, F2a, F31 and
6-keto-Fl, as standards, using paper im-
pregnated with silica gel and silver nitrate
(Stamford & Unger, 1972) and the AII
solvent system of Green & Samuelsson
(1964).
One paraffin section of tumour and normal
lung, made from each tissue taken adjacent
to the specimensextracted for prostaglandins,
was stained with haematoxylin and eosin.
Tumour types were classified according to
their degree of differentiation (i.e. well or
poorly differentiated squamous carcinomas,
adenocarcinomas and undifferentiated large-
and small-cell carcinomas).
The amount of necrosis, and the numbers
of mitotic figures, macrophages, neutrophils
andlymphocytes, wereassessedindependently
by 2 histologists (W.F.W. and F.W.) by
visual examination of the tissue sections,
using a scoring system of 0, + or + +.
These assessments mean respectively none,
few or many seen on a careful but not
exhaustive examination of one slide per
specimen, made without prior knowledge
of the prostaglandin values.
Analysis of data was carried out using the
Wilcoxon matched pairs sign-ranked test,
the Spearman Rank correlation test, the
Mann-Whitney U test and the Kruskal-
Wallis one-way analysis of variance. The
results are presented as median values
with semiquartile ranges in parentheses,
except where stated otherwise.
RESULTS
Prostaglandin-like material (PG-lm) was
assayed in extracts of tumour and lung
tissue from 171 patients. Ofthese, 37 were
excluded from the present analysis for
various reasons: pathology revealed other
tumour types (secondary, carcinoid or
benign) or tuberculosis; there was a
history of previous cancer; before the
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FIG. 1.-Amounts of prostaglandin-like
material (PG-lm), assayed against prosta-
glandin E2 and expressed as ng PGE2
equivalents/g wet tissue (vertical axis).
T represents tumour, N represents normal
lung tissue, the columns being median
values, with the vertical bars showing
semiquartile ranges. The left-hand pair are
total PG-lm (extracts of homogenates in
Krebs solution); the right-hand pair are
basal values (extracts of homogenates in
acid-ethanol). Statistically, the differences
between T and N are highly significant
(P <0.0001).
TABLE I.-Prostaglandin-like material in extracts of lung tumours and normal tissue*
Tumour
Tumour n Total
Squamous well differentiated 48 47 (22-110)
Squamous poorly differentiated 28 145 (55-460)
Adenocarcinoma well differentiated 13 170 (88-1800)
Adenocarcinoma poorly differentiated 7 86 (59-110)
Adenosquamous 3 120-300
Large-cell undifferentiated 30 37 (17-145)
Small-cell undifferentiated 4 3-44
Overall values 133 70 (24-190)
Basal
21 (12-47)
48 (19-190)
100 (49-830)
41 (34-62)
32-55
15 (5-39)
0-8-14
28 (11-79)
Normal
n Total Basal
46 31 (11-66) 15 (7-38)
29 37 (15-63) 16 (8-44)
13 37 (21-110) 26 (11-57)
7 30 (14-44) 15 (8-27)
3 37-320 18-65
30 26 (12-36) 14 (5-22)
4 19-49 0-2-63
132 33 (14-63) 16 (6-38)
* Expressed as ng PGE2 equivalents/g wet tissue. The results are medians with semiquartile ranges in
parentheses, or ranges when n=3 or 4.
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FIG. 3.-Total prostaglandin-like material
(ng PGE2 equivalents/g) in relation to
the number of tumours with mitotic
figures (Mitoses) shown as a fraction of the
total number of tumours of various types
(squamous and adenocarcinomas, well and
poorly differentiated; large and small-cell
tumours, undifferentiated; symbols as in
Fig. 2). The squamous tumours more
frequently had mitotic figures than did
the adenocarcinomas.
and Table I. Overall, amounts from
tumours were greater than from normal
lung tissue (P< 0.0001). However, of the 4
small-cell carcinomas 3 yielded less PG-lm
than did normal lung.
Well-differentiated squamous carci-
nomas were the largest group (35%), whereas there were few adenosquamous
_ 29 _ 4 (2%) and undifferentiated small-cell (3%)
Ic sc carcinomas (Table I). The yields ofPG-lm
0 varied with the tumour type (Table I).
e material Highest amounts of total PG-lm were
tissue re- obtained from well-differentiated adeno-
Lrs (squam- carcinomas, being 170 (88-1800) ng PGE2 11 (w) and
large (1c) equivalents/g, n= 13; lowesttotalamounts
Ldifferentia- were extracted from undifferentiated
ignificantly small-cell carcinomas (range 3-44ng PGE2
mour type. equivalents/g, n=4). More PG-lm was
obtained from poorly differentiated
squamous carcinomas than from well
taken drugs differentiated cancers ofthis type (P<0*01
3ynthes sre or for both basal and total PG-lm), whereas Theremain- less PG-lm was produced by poorly comprised 26 differentiated than by well differentiated
adenocarcinomas. In contrast to the varia-
basal PG-lm tions in tumourPG-lm, amounts from the
zofdituFmour normal tissue were similarregardless ofthe ized in Fig. 1associated tumour types (Fig. 2).
The number of mitotic figures was
greater in squamous carcinomas than in
o adenocarcinomas (P=0-0048 and 0-048
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FIG. 4.-Tumour total prostaglandin-like
material (ng PGE2 equivalents/g) showing
a weak inverse correlation (P<0.2) with
the numbers of mitotic figures. The
amount tended to be higher with 0 mitoses
compared with + + mitoses (P= 0.052).
Mitoses 0, +, + + represent zero, moderate
or numerous mitotic figures seen.
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FIG. 5.-Total tumour prostaglandin-like
material (ng PGE2 equivalents/g) in
relation to the numbers of neutrophils
(open columns) or degree of necrosis
(hatched columns).
respectively for well and poorly differenti-
ated tumours respectively; Fig. 3). Over-
all, total PG-lm showed a weak inverse
correlation (P< 0 2) with the mitotic figure
score (Fig. 4), and tended to be greatest
when necrosis or neutrophil content were
moderate (Fig. 5). Samplesofmacroscopic-
ally normal lung tissue were examined
histologically for lymphocytes, neutro-
phils, macrophages, haemorrhage and the
degree of fibrosis. Mainly macrophages
were seen, and their numbers corre-
lated with amounts of PG-lm (total
P < 0-001, basal P< 0 05, n= 132 and 131
respectively).
The tumours were divided into 4 groups
according to size (mean diameters (d) of
<3 cm; 3 to <5; 5 to <7 and >7 cm;
Soorae & Abbey Smith, 1977). All the un-
differentiated small-cell carcinomas, and
about half of each other type, were of d3
to < 5 cm. Overall, 17% were ofd< 3 cm,
19% were 5 to < 7, and 10%, d) 7. Well
and poorly differentiated squamous carci-
nomas showed great differences in PG-lm
according to tumour size, but it was not
feasible in those groups with small num-
bers to analyse this statistically. Poorly
differentiated squamous tumours of <3
cm diameter yielded highest amounts of
PG-lm, in contrast to the low amounts
from well differentiated tumours of the
same size (respectively 440 (150-2800) ng
and 22 (4-34) ngPGE2 equivalents/g, n= 6
and 7).
Chromatography of 34 samples showed
material that chromatographed with the
Rf of PGE2 in 31 cases, and on average it
accounted for 54% of the biological
activity on rat gastric fundus. In 26
samples there was material, representing
on average 13% of total biological
activity, which chromatographed at the
Rf of PGE1; substances that chromato-
graphed with 6-keto-PGF1cJ/PGFIa and
with PGF2X accounted for 5% (11 sam-
ples),and 6% (22 samples) ofthe biological
activity. Overall, > 20% of the remaining
activity was distributed throughout the
chromatograms and did not correspond
with any of the authentic standards
chromatographed (PGs E1, E2, E3, Fla,
F2X, F3a, and 6-keto-Fi,). Poorly differ-
entiated squamous carcinomas yielded the
highest percentage of PGE2-like activity,
and also yielded high amounts of total
biological activity. Comparatively low
amounts of PGE2-like activity were pro-
duced by well differentiated squamous
carcinomas and undifferentiated large-cell
carcinomas, in agreement with the lower
amounts ofbiological activity found in the
unchromatographed extracts (Table II).
The rat fundic strip responded to some
10mmr
5cm
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FIc. 6.-Contractions of rat gastric fundus to
tumour extract (e, shown in ml) and to
PGE2 (shown as numbers representing ng)
added to the 5ml bath. The extract used
in the left-hand tracing produced a faster
contraction than PGE2 and a faster
relaxation after wash-out (contact time
1-5 min). In the right-hand trace, re-
sponses to the extract and PGE2 had a
similar shape.
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TABLE II. The amounts ofPG-lm as a percentage of total biological activity*
Tumour type
Poorly differentiated squamous
Poorly differentiated adenocarcinoma
Well differentiated squamous
Undifferentiated large cell
N %PGE1 %PGE2 %PGE1+PGE2
13 7 72 79
4 9 62 71
9 19 39 58
8 15 41 56
Biological activity
(ng PGE2 equiv/g)
145 (55-460)
86 (59-110)
47 (22-110)
37 (17-145)
* Assayed against PGE2 after chromatographic separation of different tumour extracts (homogenates in
Krebs solution). Results are shown as ng PGE2 equivalents/g, given as median values with semiquartile
ranges in parentheses. N=number of specimens.
extracts with contractions similar to those
obtained with PGE2. In other cases the
responses were faster, and the tissue
relaxed more quickly on washout, indica-
ting that non-PGE2-like biological activity
was present (Fig. 6).
DISCUSSION
In common with most other malignant
tumours (Bennett, 1979, 1982), human
lung carcinomas can yield substantial
amounts of prostaglandins. The methods
used in this paper do not identify the
substances measured by bioassay, but
using gas chromatography-mass spectro-
metry we have recently identified various
prostaglandins and related substances in
extracts of human lung carcinomas and
normal tissue (Hensby et al., 1982).
These include arachidonic acid, 6-Keto-
PGFla, thromboxane B2 and 12-HETE.
Our bioassay results on unchromato-
graphed extracts therefore represent the
biological activity of a mixture of
acidic lipids. This has the advantage of
relating our histological findings to the
total biological activity detected by the
assay tissue, but has the disadvantage of
not identifying and quantitating the
individual components. Furthermore, the
rat gastric fundus responds poorly to
certain prostanoids, e.g. 6-keto-PGF1a,
which could therefore be present in large
amounts but make little contribution to
the measured biological activity. The
interpretation ofbioassay results has been
discussed more fully elsewhere, together
with the sources (malignant cells, host
tissues, etc.) and effects of prostaglandins
(Bennett, 1979, 1982). Histological assess-
ment is also beset with difficulties, for
example in relation to variations through-
out the tumour which would be undetec-
ted by examination of only one section.
However, the section studied was adjacent
to the piece extracted for prostaglandins.
Median amounts of prostaglandin-like
material (PG-lm) from normal lung were
similar regardless ofthe type ofassociated
tumour. In contrast, amounts of PG-lm
from tumours varied greatly according to
type, and were usually greater than from
the normal tissue. With squamous carcino-
mas the yield of PG-lm was greater from
poorly than from well differentiated
tumours, thus indicating an inverse rela-
tionship to prognosis. This is similar to the
finding with breast tumours (Bennett et
al., 1977, 1979; Rolland et al., 1980).
The otherlung tumours seem to show an
opposite relationship to squamous lung
tumours and to breast carcinomas. Prog-
nosis with lung tumours is presumably:
well differentiated adenocarcinomas >
poorly differentiated adenocarcinomas >
undifferentiated (large- and small-cell)
tumours, which parallels the amounts of
extracted PG-lm. Many mitotic figures
might seem to suggest a badprognosis, but
Weiss (1971) found no correlation between
the mitotic index and prognosis. Neverthe-
less, judged from single sections, the
numbers showed an inverse relationship to
tumour PG-lm. Furthermore, the median
tumour yield of total PG-lm in patients
surviving more than 2 years after surgery
was approximately 3 times more than
those surviving 2 years or less (preliminary
unpublished data). Evidence from animal
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studies is variable (see Bennett, 1979,
1982), but some studies in vitro demon-
strate that prostaglandins can inhibit cell
proliferation (e.g. Johnson & Pastan, 1971)
and PGE2 stimulates the differentiation of
mouse neuroblastoma cells in culture
(Prasad, 1972).
The importance of prostaglandins in
lung tumours remains to be determined,
and the findings must be interpreted
cautiously. Apart from the numerous
problems of tumour variations, method-
ology, and different effects of various
prostaglandins, our patients are a selected
sample since only about 20% of lung
cancer patients are treated surgically.
However, if our results reflect the biology
of the tumour in vivo they could be of
clinical value, and could influence the use
of drugs which alter prostaglandin meta-
bolism. The possibility arises that inhibi-
tion ofprostaglandin synthesis might have
beneficial or deleterious effects, depending
on the type ofcancer.
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